Earnings Labs

OSI Systems, Inc. (OSIS)

Q1 2015 Earnings Call· Thu, Oct 23, 2014

$286.24

-1.75%

Key Takeaways · AI generated
AI summary not yet generated for this transcript. Generation in progress for older transcripts; check back soon, or browse the full transcript below.

Same-Day

+0.44%

1 Week

+3.06%

1 Month

+4.04%

vs S&P

-2.29%

Transcript

Operator

Operator

Good day, ladies and gentlemen, and welcome to the First Quarter 2015 OSI Systems Earnings Conference Call. My name is Glen, and I will be your event manager for today. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes. I would now like to turn the conference over to your host for today, Mr. Alan Edrick, Chief Financial Officer. Please proceed, sir.

Alan I. Edrick

Analyst

Good morning, and thank you for joining us. I'm Alan Edrick, Executive Vice President and CFO of OSI Systems. And I'm here today with Deepak Chopra, our President and CEO. Welcome to the OSI Systems' First Quarter Fiscal 2015 Conference Call. We'd like to extend a special welcome to anyone who is a first-time participant on our conference calls. Please note that this presentation is being webcast and is expected to remain on our website, located at www.osi-systems.com, for approximately 2 weeks. Earlier today, we issued a press announcing our first quarter fiscal year 2015 financial results. Before we discuss our financial and our operational highlights, I'd like to read the following statement. In connection with this conference call, the company wishes to take advantage of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995 with respect to statements during this call that may be deemed to be forward-looking statements under the Act. Forward-looking statements relate to the company's current expectations, beliefs, projections and similar expressions and are not guarantees of future performance or outcomes. Forward-looking statements involve uncertainties, risks, assumptions and contingencies, many of which are outside the company's control, that may cause actual results or outcomes to differ materially from those described in or implied by any forward-looking statement. Such statements include, without limitation, information provided regarding expected revenues and earnings in fiscal 2015 and statements regarding the expected overall financial and operational performance of the company and its operating divisions. The company wishes to caution participants on this call that numerous factors could cause actual results to differ materially from these forward-looking statements. These factors include the risk factors set forth in the company's last annual report on Form 10-K and other risks described in documents subsequently filed by the company with the…

Deepak Chopra

Analyst

Thank you, Alan, and again, good morning, and welcome to the OSI Systems' Earnings Conference Call for the First Quarter of Fiscal 2015. As Alan mentioned, we had a good start to fiscal 2015 and the first quarter, led by continued strong growth in our Security division. The results have placed us in a good position to build upon this momentum for the remainder of the year. Let us review the highlights for the quarter, starting with the Security division, Rapiscan Systems, where revenues increased 17% to $113 million. There were several accomplishments in the quarter that I would like to discuss. During the quarter, we continued to successfully deliver on the Foreign Military Sales contract from the Department of Defense to supply multiple units of cargo and vehicle inspection systems and related training spare parts service and logistic support to Iraq. In addition to the FMS contract, our overall equipment sales were robust as we experienced increased activity from several regions of the world. As an example, during the quarter, our Security inspection systems were utilized at the 2014 Glasgow Commonwealth games. In turnkey services, current programs continue to strongly contribute to Rapiscan's overall performance, and we continue to pursue a number of new opportunities for additional turnkey security solutions. We are optimistic about new turnkey customers coming about in the future. Our advanced CT hold baggage solution, the RTT, continues to be evaluated by the DSA for the inspection of checked-baggage at airports, and we are hopeful to receive certification by fiscal year end, but there is no guarantee. As you may know, RTT has already passed the European Civil Aviation Conference (ECAC) Standard 3 threat detection test for standard and large tunnel size configurations. We have a growing pipeline of potential RTT customers and expect new bookings…

Alan I. Edrick

Analyst

Thank you, Deepak. Our ongoing effort to deliver meaningful revenue and earnings growth through higher-margin growth initiatives and operating improvements continues to prove successful. Let's review in greater detail the financial results for the first quarter of the fiscal year before discussing our updated fiscal 2015 guidance. As mentioned earlier, our revenues in the first quarter increased 6% over Q1 of fiscal '14. This was primarily due to the 17% revenue growth in the quarter in our Security division resulting from strength in our core baggage and parcel inspection products, new product launches and the partial fulfillment of the large FMS contract entered into in June of 2014. Our Opto division's revenues decreased 3% as a result of lower contract manufacturing sales, given the tough comp that Deepak just alluded to, due to a large international stocking order in the prior year, offset partially by strong intercompany sales. Revenues in our Healthcare division increased a modest 4%, resulting from the acquisition of the cardiology business that Deepak just mentioned. While sales in North America to the hospital market improved, softness in Europe offset such gains. Healthcare bookings picked up with a book-to-bill ratio of 1.2 in Q1, providing a cautious degree of optimism. Our gross margin came in at 34%, an increase of 110 basis points as compared to Q1 in the prior year. This improvement was driven by a number of factors, including, one, the growth of Security revenues and a favorable product mix; and, two, the impact of the decrease in revenue in our Opto Division, which typically carries the lowest gross margin in the company's 3 divisions. As mentioned on previous calls, the margin will fluctuate from period-to-period based on revenue mix amongst other factors. Moving to OpEx. In Q1 of fiscal '15, SG&A as a percentage…

Operator

Operator

[Operator Instructions] And your first question comes from the line of Josephine Millward with Benchmark Company.

Josephine Lin Millward - The Benchmark Company, LLC, Research Division

Analyst

Can you give us your Security bookings during the quarter or a breakdown of your backlog between Security and non-Security?

Alan I. Edrick

Analyst

Josephine, this is Alan. Our book-to-bill ratio for Security, excluding turnkey, was 0.9, so it was pretty healthy bookings. As you know, we don't break down the backlog specifically between the various divisions, but our backlog did approximate about $800 million.

Josephine Lin Millward - The Benchmark Company, LLC, Research Division

Analyst

Sorry, I missed the book-to-bill, what -- did you say 0.9?

Alan I. Edrick

Analyst

That's correct, excluding our turnkey business.

Josephine Lin Millward - The Benchmark Company, LLC, Research Division

Analyst

Okay. Can you give us an update on Mexico and how that's progressing, whether you expect to hit full run rates this year?

Deepak Chopra

Analyst

Josephine, I think what we said in the last conference call, Alan said that they are pretty much to the level of full operation. Obviously, there's going to be a little bit of improvement. But the present numbers basically reflect on going forward what the present expectations of the revenue is from the Mexico contract, unless there is any increase in the number of locations as they move forward. But we are looking at it as if we have reached to the full load. Alan, do you want to add to anything?

Alan I. Edrick

Analyst

I think that's good assessment. Yes.

Josephine Lin Millward - The Benchmark Company, LLC, Research Division

Analyst

So just to clarify, so that's roughly $135 million a year for Mexico at almost a 100% run rate?

Alan I. Edrick

Analyst

At a run rate based on where we're going today, it would be just a little bit south of that, yes.

Josephine Lin Millward - The Benchmark Company, LLC, Research Division

Analyst

Great. And last question is an update on Albania, whether there's -- we could hear about a resolution anytime soon?

Deepak Chopra

Analyst

Well, Josephine, you know our position. Anything that is not definite, we never talk about it. All we can say is we are continuing to work the issues out, and hopefully, we reach to an amiable conclusion.

Operator

Operator

And your next question comes from the line of Brian Ruttenbur with CRT Capital.

Brian W. Ruttenbur - CRT Capital Group LLC, Research Division

Analyst · CRT Capital.

Couple of questions. First of all, housekeeping on Alan, the share buyback you bought 400,000 shares. What was the average price?

Alan I. Edrick

Analyst · CRT Capital.

We haven't gotten to that specifically, Brian, but you could probably do the math a little bit. We spent roughly $25 million, and we bought just south of 400,000 shares. So you can see it'd be in the $60.

Brian W. Ruttenbur - CRT Capital Group LLC, Research Division

Analyst · CRT Capital.

Right around $60. Right. Yes, right around $60. Okay, I didn't know if you had the exact calculation. The -- I guess, the buyback that you have in place right now account for, I believe, what, another $51 million? Is that right? Or $50 million?

Alan I. Edrick

Analyst · CRT Capital.

Yes. We do have an authorized program for a number that's probably a little bit above the amount you just described.

Brian W. Ruttenbur - CRT Capital Group LLC, Research Division

Analyst · CRT Capital.

Okay. And maybe turning over to Deepak, in terms of your plan for buybacks, you're going to generate at least, according to us on the Street, north of $100 million of free cash flow this year. Is there a plan to expand that buyback? Is there a plan to use leverage to increase the buyback?

Deepak Chopra

Analyst · CRT Capital.

Well, Brian, you know that it's a subject that we continue to look at it. And from time to time, we buy. I'm not going to go into any details. Obviously, we have a strong balance sheet and we look at all the opportunities, buyback, acquisitions, turnkey services and whatever. But we do look at it, Alan and I and the board are very sensitive to it, and from time to time, we are very much focused into this particular subject.

Brian W. Ruttenbur - CRT Capital Group LLC, Research Division

Analyst · CRT Capital.

Okay. And then in terms of your acquisition, can you talk about how much you paid for that recent Healthcare acquisition?

Alan I. Edrick

Analyst · CRT Capital.

Brian, this is Alan. We paid roughly $9 million.

Brian W. Ruttenbur - CRT Capital Group LLC, Research Division

Analyst · CRT Capital.

$9 million. Okay. Is that why there was an increase in your bank line from last quarter to this quarter?

Alan I. Edrick

Analyst · CRT Capital.

Yes. The increase in the bank line was just related to the timing: A little bit with the acquisition, a little bit would be the stock buyback we just talked about, and general working capital, yes.

Brian W. Ruttenbur - CRT Capital Group LLC, Research Division

Analyst · CRT Capital.

Okay. And then in terms of the FMS order in Iraq. Can you -- I think you shipped last quarter, June, 11 units. Are you talking in number of units that you shipped this quarter or any kind of projections for the next couple of quarters?

Alan I. Edrick

Analyst · CRT Capital.

Well, Brian, this is Alan. I guess, what we could describe is, as we said in the last call, the Q1 would be a bit less than the Q4. And that proved to be true. We recognized revenues of roughly $14 million, $15 million orders from FMS in Q1. And also as we mentioned last quarter, we thought Q2 would pick up. While we don't want to give a precise number, we do think it will be above the Q1 number.

Operator

Operator

Your next question comes from the line of Jeff Martin with ROTW Capital Partners (sic) [Roth Capital Partners].

Jeff Martin - Roth Capital Partners, LLC, Research Division

Analyst

Alan, can you give us an idea of what kind of revenue run rate that AED acquisition has at close? And what day did it close?

Deepak Chopra

Analyst

Would you repeat that again, Jeff?

Jeff Martin - Roth Capital Partners, LLC, Research Division

Analyst

What's the revenue run rate of the acquired AED business that you just bought?

Deepak Chopra

Analyst

About $16 million to $20 million, but it's basically varies. And I think, Alan, we are, what, 1 month into it?

Alan I. Edrick

Analyst

Yes, Jeff, we've just had it a short time. We purchased it midway through the quarter.

Jeff Martin - Roth Capital Partners, LLC, Research Division

Analyst

Okay. And then is that a product you're going to bring into the domestic market?

Alan I. Edrick

Analyst

No. Our plan for that product line is really on an international basis. So we're really focused on our distributor network and some of our channels outside the United States.

Jeff Martin - Roth Capital Partners, LLC, Research Division

Analyst

Okay. And then is your higher guidance essentially accounting for the acquisition?

Alan I. Edrick

Analyst

That is correct.

Jeff Martin - Roth Capital Partners, LLC, Research Division

Analyst

And then EPS is a little better just operationally?

Alan I. Edrick

Analyst

That's correct, as well.

Jeff Martin - Roth Capital Partners, LLC, Research Division

Analyst

Okay. You had been, in the past, talking about ramping up production for Arkon. Are you still ramping that? Are you producing units? How's Arkon coming along?

Deepak Chopra

Analyst

The answer is yes. We continue to go into production, and we think that there'll be relatively more contribution into the revenue in the second half of this year compared to before with the Arkon product line.

Jeff Martin - Roth Capital Partners, LLC, Research Division

Analyst

Okay. And then in terms of the government mandated replacement of airport screening equipment, do you have any trends that are worth noting in terms of that starting to come more into light? Do you have expectations that, that will start to kick in more this year? What's your view there?

Deepak Chopra

Analyst

We just watch and see. All over the world, the U.S. is different than the rest of the world. We look at it very closely. But there is no specific trends that we look at, which is going to change anything differently significantly.

Jeff Martin - Roth Capital Partners, LLC, Research Division

Analyst

Okay. And then, Alan, I didn't catch the cash flow from operations number. Could you give that again, please?

Alan I. Edrick

Analyst

Sure. It was $31.5 million.

Operator

Operator

[Operator Instructions] And your next question comes from the line of William Lee with Oppenheimer. William Lee - Oppenheimer & Co. Inc., Research Division: If I look at the margins in Rapiscan in the first quarter, it looks really strong. Can you maybe parse out how much of this is from the equipment sales? How much is from turnkey? And how should we think about the margins on the FMS businesses? Does this drive, in part, that improvement?

Alan I. Edrick

Analyst

So Will, this is Alan. Thanks for the question. As you know, we don't break out our margins by our various product lines or business areas within the division. We were very pleased with the margin improvement in the Security business, and FMS certainly contributed to that. William Lee - Oppenheimer & Co. Inc., Research Division: Right, right. But if we think about in terms of Mexico, Mexico this quarter and last quarter were pretty much at full run rate. Is that fair?

Alan I. Edrick

Analyst

The Mexico revenue was not significantly different in Q1 from Q4. That is a fair statement. William Lee - Oppenheimer & Co. Inc., Research Division: Okay. Great. And you also mentioned that CapEx this year is going to be elevated. How should we think about it? Is this something where it's going to be comparable to last year? Or is it still -- is it going to still be down year-over-year?

Alan I. Edrick

Analyst

So Will, I think my comments referred to R&D, that R&D was a little bit higher than it was last year. CapEx, we anticipate to be down year-over-year, absent new turnkey wins, which we, of course, hope to win.

Operator

Operator

And your next question comes from the line of Josephine Millward with Benchmark.

Josephine Lin Millward - The Benchmark Company, LLC, Research Division

Analyst · Benchmark.

Deepak, can you talk about your Security pipeline and the macroenvironment? As you know, most of your competitors appear to be struggling. If you can comment on that, your outlook in general.

Deepak Chopra

Analyst · Benchmark.

Josephine, as Alan mentioned, our non-turnkey, our bookings from Q1 were very good, at 0.9 book-to-bill. We look at -- especially in the international sector, we are not seeing something what some of these other competitors have reported, and we basically attribute that to, we have a very broad product line and that has always been our strategy, and we have a very broad global reach. And that does help, and we look at it that the pipeline continues to be robust. Our guideline reflects that. We look at it that the international arena especially would be very difficult [ph].

Josephine Lin Millward - The Benchmark Company, LLC, Research Division

Analyst · Benchmark.

Okay. The same [ph] on RTT, and you currently bidding on international projects, do you think we could see some deliveries this year, this fiscal year?

Deepak Chopra

Analyst · Benchmark.

The answer is definitely, yes. There will be some deliveries. I just want to make sure that you don't -- because we already have booked orders. So what it means is that we will have deliveries, that's one part of your question. And we also said in my script that we expect, anticipate some new bookings in the RTT product line internationally in the remainder of the year.

Josephine Lin Millward - The Benchmark Company, LLC, Research Division

Analyst · Benchmark.

That's great. One final question. I think, Alan, you mentioned that new product launch in Security was one of the growth drivers. Can you expand on that and talk about what the new product was in Security?

Alan I. Edrick

Analyst · Benchmark.

Sure, Josephine. We launched a product, a small product in the trace detection area called DETECTRA, which we are looking forward to getting some market penetration throughout that area. So it's a -- we call it a smaller product line, but it's an attractive product line that goes well into the sales mix and fits right into the bag of tricks for our sales channel and our distributors.

Deepak Chopra

Analyst · Benchmark.

And just add to on to it, we also have introduced additional mobile cargo products in the low energy mode, and we are very excited about it.

Operator

Operator

At this time, we have no further questions. I will now turn the call over to Mr. Deepak Chopra for closing remarks.

Deepak Chopra

Analyst

Well, thank you very much. I would like to thank everyone for joining our call. We look forward to speaking with you again on our next call, and we continue to remain optimistic and very excited about our year end and are looking forward to talking to you next quarter call. Thank you.